Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Humoral and cellular immune responses to CoronaVac up to one year after vaccination

Frontiers in Immunology(2022)10.3389/fimmu.2022.1032411Source: DataRank Database

Humoral and cellular immune responses to CoronaVac up to one year after vaccination is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 27 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access27 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.52)OA: goldTopics (37)Linked Datasets (6)DataCite Reuse (6)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Carolina Argondizo Correia ORCID,Mariana Prado Marmorato ORCID,Juliana Zanatta de Carvalho Dias ORCID,Mateus Vailant Thomazella ORCID,Amanda Cabral da Silva ORCID

Live enrichment

PubMed:36341425 OpenAlex:https://openalex.org/W4306968936

Fundação de Amparo à Pesquisa do Estado de São Paulo

Grant: 2020/10127-1, 2020/06409-1

National Institutes of Health

Grant: 75N93019C00065

Bill and Melinda Gates Foundation

Grant: INV-021239

FWCI

2.52

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3389/fimmu.2022.1032411

publisherhttps://doi.org/10.3389/fimmu.2022.1032411

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.1032411/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36341425

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9634255

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesvaccines and immunoinformatics approachesHumansAntibodies, ViralCOVID-19COVID-19 VaccinesCytokinesImmunity, CellularImmunoglobulin GSARS-CoV-2Vaccination

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesAntibodies, ViralHumansImmunoglobulin GImmunity, CellularVaccinationCytokines

Keywords

ImmunologyImmune systemCytokineAntigenVaccinationMemory B cellMemory T cellAntibodyMedicineBiologyT cellB cellCoronaVaccellular responsehumoral responseimmune memory

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Detection of IgG antibodies against the receptor binding domain of the spike protein and nucleocapsid of SARS-CoV-2 at university students from Southern Mexico: a cross-sectional study

10.6084/m9.figshare.26027458.v1figshare

10.6084/m9.figshare.26027458figshare

Additional file 2 of Detection of IgG antibodies against the receptor binding domain of the spike protein and nucleocapsid of SARS-CoV-2 at university students from Southern Mexico: a cross-sectional study

10.6084/m9.figshare.26027709.v1figshare

10.6084/m9.figshare.26027709figshare

Additional file 3 of Detection of IgG antibodies against the receptor binding domain of the spike protein and nucleocapsid of SARS-CoV-2 at university students from Southern Mexico: a cross-sectional study

10.6084/m9.figshare.26733238.v1figshare

10.6084/m9.figshare.26733238figshare